Scarica l'app Stockscreener
38.54
1.82%
0.69
Dopo l'orario di chiusura:
38.65
0.11
+0.29%
Astrana Health Inc Borsa (ASTH) Ultime notizie
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack - TradingView
Astrana Health Q1 2026 slides: 56% revenue growth, full-risk shift accelerates - Investing.com Nigeria
Astrana Health closes deal with Prospect Health at a lower price - MSN
A Look at Astrana Health Inc (ASTH) After 3.5% Decline -- GF Val - GuruFocus
Cash-Rich Stocks: Appian and Array Face Challenges, Astrana Health ShinesNews and Statistics - IndexBox
Is Astrana’s Q1 Results and AI Platform Push Altering The Investment Case For Astrana Health (ASTH)? - Yahoo Finance
Astrana Health (ASTH) price target increased by 18.07% to 44.43 - MSN
52-Week High Stocks: Sell EchoStar, Watch Vita Coco and Astrana HealthNews and Statistics - IndexBox
Astrana Health (ASTH) COO and CFO surrenders 8,155 shares for tax withholding - Stock Titan
Astrana Health partners with California physician group By Investing.com - Investing.com Nigeria
Astrana Health says Prospect deal is ahead of schedule as Q1 trends beat expectations - MSN
Astrana Health Q1 2026 Results: Revenue Beat and AI-Driven Growth - IndexBox
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call - Yahoo Finance
Will Strong Q1 Results and New Leadership Shift Astrana Health's (ASTH) Value-Based Care Narrative - simplywall.st
Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Bristol-Myers Squibb (BMY) and Progyny (PGNY) - The Globe and Mail
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47 - Moomoo
Truist raises Astrana Health stock price target to $47 on outlook - Investing.com UK
Truist raises Astrana Health stock price target to $47 on outlook By Investing.com - Investing.com South Africa
BofA Securities Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Updates Investor Presentation via Regulation FD Disclosure - The Globe and Mail
Astrana Health Inc.Common Stock (NQ: ASTH - FinancialContent
Astrana Health names George Christides interim medical director By Investing.com - Investing.com Australia
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations - Inkl
Astrana Health names George Christides interim medical director - Investing.com UK
ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results - Yahoo Finance
Astrana Health announces appointment of interim national medical director - marketscreener.com
Astrana Health, Inc. Announces Appointment of Interim National Medical Director - PR Newswire
Astrana outlines $3.8B-$4.1B 2026 revenue outlook as net leverage targets at or below 2x - MSN
Astrana Health Announces Upcoming Chief Medical Officer Resignation - TipRanks
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 - Investing.com
Astrana Health chief medical officer Dinesh Kumar to resign effective June 1 By Investing.com - Investing.com South Africa
Astrana Health (NASDAQ: ASTH) CMO Dinesh Kumar plans June 1, 2026 exit - Stock Titan
Astrana Health (NASDAQ: ASTH) posts updated May 2026 investor presentation - Stock Titan
Astrana Health partners with California physician group - Investing.com UK
Astrana Health : Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care - marketscreener.com
Earnings call transcript: Astrana Health Q1 2026 Surpasses Expectations with Strong EPS and Revenue Growth - Investing.com Nigeria
Astrana Health partners with PAC to boost independent physicians via AI-driven Medicare ACO platform. - Pluang
2.01%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):